The Neurofibromatosis Drugs Market is benefiting from increasing attention to rare diseases and unmet treatment needs. Pharmaceutical and biotechnology companies are investigating therapies that can address tumor growth, disease progression, and associated complications. The global Neurofibromatosis Drugs Market was valued at US$ 3.45 Billion in 2025 and is expected to reach US$ 12.34 Billion...